Background: This study aimed to investigate the association between PSA Density and Gleason score of the positive margin after radical prostatectomy with biochemical recurrence in patients with prostate cancer. Materials and methods: In this retrospective cohort study, patients with prostate cancer referred to Hasheminejad Hospital in Tehran during 2009–2019, who underwent radical prostatectomy were assessed to enter the study. Patients were selected by the convenience sampling method. The follow-up period was determined as at least 1 year after radical prostatectomy to determine biochemical recurrence. PSA Density (PSAD) and the Gleason score of surgical specimen and positive surgical margins (PSM) were evaluated and their association with biochemical recurrences was investigated. Results: One hundred and three patients entered the study. The overall biochemical recurrence rate was 48.5% with a mean follow-up of 24 months (12–42 months) and an average time to biochemical recurrence of 18 months (16–20 months). BCR-free survival rates of patients divided based on to the PSAD cut-off point (0.205 ng/ml/cc) were significantly different using the log-rank test ( p = 0.008) (85.7%, 57.1%, and 14.3% for values ⩽0.205 ng/ml/cc vs 55.8%, 20.9%, and 0% for values ˃0.205 ng/ml/cc, respectively for 1-, 2- and 3-year survival). In addition, Cox regression showed that the Gleason score of PSM, the Gleason score of the surgical specimen, and the PSAD predicted biochemical recurrence to most extent, respectively. Conclusion: PSAD and PSM Gleason score were strong predictors of biochemical recurrence after radical prostatectomy and their use along with other common indicators including tumor grade and stage and PSA level can increase the accuracy of risk assessment in patients with prostate cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.